This is reflected in guidance from the British Obesity and Metabolic Surgery Society (BOMSS)
The best of these [peptides and peptide stacks] have promising data in laboratory animals, but very little evidence in humans
Research interest includes appetite-pathway studies, energy-balance research, hepatic lipid-metabolism research, and incretin-signaling investigations
At this time: Long term safety data is not available Human dosage guidelines are not established Side effects are not fully documented Use remains research based It should not be used casually or without medical supervision
Blood Flow, Nitric Oxide, and Angiogenesis BPC 157 may also influence nitric oxide pathways and angiogenesis
Disclosure of interest: hak Lam Ip: Nothing to disclose Jonathan Hayton: Nothing to disclose Selina Edwards: Nothing to disclose Sohaa Jamil: Nothing to disclose Ken Crossley: Nothing to disclose Rajaram Bathula: Nothing to disclose Soma Banerjee: Nothing to disclose Rob Simister: Nothing to disclose